Personalized Medicine Market Foraying Marvelous Growth in the US

With significant advancements in technological area, the US personalized medicine market is anticipated to grow at a CAGR of 9.5% during 2009-2015, says RNCOS.

Noida, India (prHWY.com) May 25, 2012 - According to our new research report, "Personalized Medicine Market Analysis", personalized medicine has transpired as an essential field for companies in both the pharmaceutical and the diagnostic industries. This is evident from the fact that major players of the industry are foraying investments in the industry. The total market for personalized medicine in the US alone was estimated to be US$ 18 Billion in 2009 and is further likely to grow at a CAGR of 9.5% during 2009-2015.

Our report has found that the number of personalized medicine technologies being commercialized in Europe has quadrupled from 2006 to 2011. Moreover, to tap the fast growing sector; several European countries are investing heavily in the research and development of novel personalized medicine technologies. The funding promises a commitment to the future growth of this area. Countries, such as France, United Kingdom, and Sweden have already adopted effective measures to strengthen the market potential.

Further, our report provides extensive information and rational analysis of the global personalized medicine market and effectively investigates current market trends and industrial developments to enable clients with a proper understanding of the market structure and its future outlook. Our team of experts have prudently evaluated all the collected information and presented it in a chronological manner to depict a meaningful and clear picture of the global personalized medicine market.

The report covers almost all the key aspects of the global personalized medicine market and examines the key drivers and restraints that may have an impact on the market performance. Forecast in key areas of the report makes use of effective methods and techniques that seek to provide a realistic overview of the market. The study also provides an insight into the segment-wise competitive landscape that includes the profiles of Pharmaceutical/Biotech, Diagnostic, IT/Informatics, and Research Tool companies across the globe. Overall, the report is meant to provide clients with an optimum outlook on the global personalized medicine market.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM305.htm

Some of our Related Reports are:

- Global Telemedicine Market Analysis (http://www.rncos.com/Report/IM331.htm)
- Global Regenerative Medicine Market (http://www.rncos.com/Report/IM363.htm)
- Emerging Pharmaceutical Markets Globally
(http://www.rncos.com/Report/IM081.htm)
- Booming Clinical Trials Market in India (http://www.rncos.com/Report/IM564.htm)
- Global Obesity Drug Market Analysis (http://www.rncos.com/Report/IM335.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.

###

Tag Words: personalized medicine

Categories: Biotech

Press Release Contact
B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707

Link To This Press Release:

URL HTML Code